Stock Scorecard
Stock Summary for Amicus Therapeutics Inc (FOLD) - $14.37 as of 3/3/2026 7:49:19 PM EST
Total Score
6 out of 30
Safety Score
32 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for FOLD
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for FOLD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for FOLD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for FOLD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for FOLD (32 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 5 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 2 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for FOLD
Financial Details for FOLD
Company Overview |
|
|---|---|
| Ticker | FOLD |
| Company Name | Amicus Therapeutics Inc |
| Country | USA |
| Description | Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing and delivering drugs for people living with rare metabolic diseases. The company is headquartered in Philadelphia, Pennsylvania. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 14.37 |
| Price 4 Years Ago | 12.21 |
| Last Day Price Updated | 3/3/2026 7:49:19 PM EST |
| Last Day Volume | 3,638,453 |
| Average Daily Volume | 5,895,720 |
| 52-Week High | 14.38 |
| 52-Week Low | 5.51 |
| Last Price to 52 Week Low | 160.80% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 24.45 |
| Sector PE | 61.76 |
| 5-Year Average PE | 1.38 |
| Free Cash Flow Ratio | 21.13 |
| Industry Free Cash Flow Ratio | 15.04 |
| Sector Free Cash Flow Ratio | 25.91 |
| Current Ratio Most Recent Quarter | 2.84 |
| Total Cash Per Share | 0.68 |
| Book Value Per Share Most Recent Quarter | 0.88 |
| Price to Book Ratio | 19.56 |
| Industry Price to Book Ratio | 57.35 |
| Sector Price to Book Ratio | 57.66 |
| Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Industry Price to Sales Ratio Twelve Trailing Months | 40.79 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.19 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 313,704,000 |
| Market Capitalization | 4,507,926,480 |
| Institutional Ownership | 104.07% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.10% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -95.50% |
| Annual Earnings Growth | 51.68% |
| Reported EPS 12 Trailing Months | -0.04 |
| Reported EPS Past Year | 0.11 |
| Reported EPS Prior Year | -0.14 |
| Net Income Twelve Trailing Months | -27,110,000 |
| Net Income Past Year | -27,110,000 |
| Net Income Prior Year | -56,106,000 |
| Quarterly Revenue Growth YOY | 23.70% |
| 5-Year Revenue Growth | 19.44% |
| Operating Margin Twelve Trailing Months | 8.61% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 214,010,000 |
| Total Cash Past Year | 214,010,000 |
| Total Cash Prior Year | 213,752,000 |
| Net Cash Position Most Recent Quarter | -177,975,000 |
| Net Cash Position Past Year | -176,101,000 |
| Long Term Debt Past Year | 390,111,000 |
| Long Term Debt Prior Year | 390,111,000 |
| Total Debt Most Recent Quarter | 391,985,000 |
| Equity to Debt Ratio Past Year | 0.41 |
| Equity to Debt Ratio Most Recent Quarter | 0.41 |
| Total Stockholder Equity Past Year | 274,241,000 |
| Total Stockholder Equity Prior Year | 194,045,000 |
| Total Stockholder Equity Most Recent Quarter | 274,241,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 29,849,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.10 |
| Free Cash Flow Past Year | 29,849,000 |
| Free Cash Flow Prior Year | -37,444,000 |
Options |
|
| Put/Call Ratio | 4.20 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.12 |
| MACD Signal | 0.17 |
| 20-Day Bollinger Lower Band | 7.62 |
| 20-Day Bollinger Middle Band | 12.38 |
| 20-Day Bollinger Upper Band | 17.14 |
| Beta | 0.43 |
| RSI | 72.34 |
| 50-Day SMA | 9.04 |
| 150-Day SMA | 10.52 |
| 200-Day SMA | 10.63 |
System |
|
| Modified | 3/2/2026 11:50:54 PM EST |